Seminars in Hematology
Volume 43 , Pages S13-S17 , January 2006

Update on Liver Disease in Hemophilia Patients

  • Craig M. Kessler

      Affiliations

    • Corresponding Author InformationAddress correspondence to Craig M. Kessler, MD, Chief, Division of Hematology–Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3800 Reservoir Rd NW, Washington, DC 20007.

References 

  1. Morfini M , Mannucci PM , Ciavarella N , Schiavoni M , Gringeri A , Rafanelli D , et al.  Prevalence of infection with hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates (A retrospective evaluation) . Vox Sang . 1994;67:178–182
  2. Brettler DB , Alter HJ , Dienstag JL , Forsberg AD , Levine PH . Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients . Blood . 1990;76:254–256
  3. Eyster ME , Sherman KE , Goedert JJ , Katsoulidou A , Hatzakis A . Prevalence and changes in hepatitis C virus genotype among multitransfused persons with haemophilia. The Multicenter Hemophilia Cohort Study . J Infect Dis . 1999;179:1062–1069
  4. Yee TT , Griffioen A , Sabin CA , Dusheiko G , Lee CA . The natural history of HCV in a cohort of haemophiliac patients infected between 1961 and 1985 . Gut . 2000;47:845–851
  5. Lee C , Dusheiko G . The natural history and antiviral treatment of hepatitis C in haemophilia . Haemophilia . 2002;8:322–329
  6. Franchini M , Rossetti G , Tagliaferri A , Capra F , de Maria E , Pattacini C , et al.  The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders . Blood . 2001;98:1836–1841
  7. Kroner BL , Rosenberg PS , Aledort LM , Alvord WG , Goedert JJ . HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978–1990. Multicenter Hemophilia Cohort Study . J Acquir Immune Defic Syndr . 1994;7:279–286
  8. Ragni MV , Belle SH . Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with haemophilia and hepatitis C virus infection . J Infect Dis . 2001;183:1112–1115
  9. Colombo M , Mannucci PM , Brettler DB , Girolami A , Lian ECY , Rodeghiero F , et al.  Hepatocellular carcinoma in hemophilia . Am J Hematol . 1991;37:243–246
  10. Santagostino E , Colombo M , Rivi M , Rumi MG , Rocino A , Linari S , et al.  Study Group of the Association of Italian Hemophilia Centers   A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus . Blood . 2003;102:78–82
  11. Tradati F , Colombo M , Mannucci PM , Rumi MG , De Fazio C , Gamba G , et al.  The Study Group of the Association of Italian Hemophilia Centers   A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C . Blood . 1998;91:1173–1177
  12. Gordon FH , Mistry PK , Sabin CA , Lee CA . Outcome of orthotopic liver transplantation in patients with haemophilia . Gut . 1998;42:744–749
  13. Sugawara Y , Ohkubo T , Makuuchi M , Kimura S , Morisawa Y , Tachikawa N , et al.  Living-donor liver transplantation in an HIV-positive patient with hemophilia . Transplantation . 2002;74:1655–1656
  14. Ashrani AA , Reding MT , Shet A , Osip J , Humar A , Lake JR , et al.  Successful liver transplantation in a patient with severe haemophilia A and a high-titre factor VIII inhibitor . Haemophilia . 2004;10:735–737
  15. Aledort LM , Levine PH , Hilgartner M , Blatt P , Spero JA , Goldberg JD , et al.  A study of liver biopsies and liver disease among hemophiliacs . Blood . 1985;66:367–372
  16. Ahmed MM , Mutimer DJ , Elias E , Linin J , Garrido M , Hubscher S , et al.  A combined management protocol for patients with coagulation disorders infected with hepatitis C virus . Br J Haematol . 1996;95:383–388
  17. Hanley JP , Jarvis LM , Andrews J , Dennis R , Lee R , Simmonds P , et al.  Investigation of chronic hepatitis C infection in individuals with haemophilia (assessment of invasive and non-invasive methods) . Br J Haematol . 1996;94:159–165
  18. Makris M , Preston FE , Rosendaal FR , Underwood JC , Rice KM , Triger DR . The natural history of chronic hepatitis C in haemophiliacs . Br J Haematol . 1996;94:746–752
  19. Gupta R , Druy EM , Kessler CM . Safety and potential usefulness of liver biopsy in HIV-seropositive haemophiliacs employing a transjugular venous approach . Haemophilia . 1997;3:201–204
  20. Wong VS , Baglin T , Beacham E , Wight DD , Petrik J , Alexander GJ . The role for liver biopsy in haemophiliacs infected with the hepatitis C virus . Br J Haematol . 1997;97:343–347
  21. Fukuda Y , Nakano I , Katano Y , Toyoda H , Imoto M , Takamatsu J , et al.  Assessment and treatment of liver disease in Japanese haemophilia patients . Haemophilia . 1998;4:595–600
  22. Venkataramani A , Behling C , Rond R , Glass C , Lyche K . Liver biopsies in adult hemophiliacs with hepatitis C (A United States center’s experience) . Am J Gastroenterol . 2000;95:2374–2376
  23. McMahon C , Pilkington R , Shea EO , Kelleher D , Smith OP . Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders . Br J Haematol . 2000;109:354–359
  24. Lethagen S , Widell A , Berntorp E , Verbaan H , Lindgren S . Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease . Br J Haematol . 2001;113:87–93
  25. DiMichele DM , Mirani G , Wilfredo Canchis P , Trost DW , Talal AH . Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection . Haemophilia . 2003;9:613–618
  26. Shin JL , Teitel J , Swain MG , Bain VG , Adams PC , Croitoru K , et al.  Virology and Immunology Committee of the Association of Hemophilia Clinic Directors of Canada. A Canadian multicentre retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? . Am J Hematol . 2005;78:85–93
  27. Theodore D , Fried MW , Kleiner DE , Kroner BL , Goedert JJ , Eyster ME , et al.  Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C . Haemophilia . 2004;10:413–421
  28. Stieltjes N , Ounnoughene N , Sava E , Paugy P , Roussel-Robert V , Rosenberg AR , et al.  Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus . Br J Haematol . 2004;125:769–776
  29. Zhang M , O’Brien TR , Kopp WC , Goedert JJ . Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection (A nested cross-sectional study) . BMC Blood Disord . 2005;5:2
  30. Woitas RP , Ahlenstiel G , Iwan A , Rockstroh JK , Brackmann HH , Kupfer B , et al.  Frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C . Gastroenterology . 2002;122:1721–1728
  31. Zhang M , Goedert JJ , O’Brien TR . High frequency of CCR5-Δ32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1 . Gastroenterology . 2003;124:867–868
  32. Imbert-Bismut F , Ratziu V , Pieroni L , Charlotte F , Benhamou Y , Poynard T  MULTIVIRC Group . Biochemical markers of liver fibrosis in patients with hepatitis C infection (A prospective study) . Lancet . 2001;357:1069–1075
  33. Poynard T , Imbert-Bismut F , Munteanu M , Messous D , Myers RP , Thabut D , et al.  Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C . Comp Hepatol . 2004;3:8
  34. Goedert JJ , Brown DL , Hoots K , Sherman KE . Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia . Haemophilia . 2004;10(suppl 4):205–210
  35. Carrat F , Bani-Sadr F , Pol S , Rosenthal E , Lunel-Fabiani F , Benzekri A , et al.  ANRS HCO2 RIBAVIC Study Team   Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients (A randomized controlled trial) . JAMA . 2004;292:2839–2848
  36. Honda T , Toyoda H , Hayashi K , Katano Y , Yano M , Nakano I , et al.  Ribavirin and use of clotting factors in patients with hemophilia and chronic hepatitis C . JAMA . 2005;293:1190–1192
  37. De Clercq E . Antiviral drugs (current state of the art) . J Clin Virol . 2001;22:73–89
  38. Dolin R , Reichman RC , Madore HP , Maynard R , Linton PN , Webber-Jones J . A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection . N Engl J Med . 1982;307:580–584
  39. Mangia A , Ricci GL , Persico M , Minerva N , Carretta V , Bacca D , et al.  A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naive patients with chronic hepatitis C . J Virol Hepat . 2005;12:292–299
  40. Barnard D . Viramidine (Ribapharm) . Curr Opin Invest Drugs . 2002;3:1585–1589
  41. Hinrichsen H , Benhamou Y , Wedemeyer H , Reiser M , Sentjens RE , Calleja JL , et al.  Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients . Gastroenterology . 2004;127:1347–1355
  42. Carvalho A , Leitao J , Louro E , Maia R , Geraldes C , Ventura C , et al.  Small dose of recombinant factor VIIa (rFVIIa) to perform percutaneous liver biopsies in cirrhotic patients . Rev Esp Enferm Dig . 2002;94:280–285
  43. Jureczko L , Kolacz M , Trzebicki J , Szyszko G , Pacholczyk M , Lagiewska B , et al.  Perioperative use of recombinant activated factor VII in liver transplantation . Ann Transplant . 2003;8:40–42
  44. Lodge JP , Jonas S , Jones RM , Olausson M , Mir-Pollard J , Soefelt S , et al.  Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation . Liver Transpl . 2005;11:973–979
  45. Planinsic RM , van den Meer J , Testa G , Grande L , Candela A , Porte RJ , et al.  Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease . Liver Transpl . 2005;11:895–900

PII: S0037-1963(05)00229-5

doi: 10.1053/j.seminhematol.2005.11.021

Seminars in Hematology
Volume 43 , Pages S13-S17 , January 2006

Article Tools